Author

Rabab A. El-Gazar

Observed names: R A El-Gazar, Rabab A. EL-Gazar

Institution: October 6 University

Observed institution: October 6 University

ORCID: 0000-0002-4728-5723

Observed ORCID: 0000-0002-4728-5723

OpenAlex ID: A5065057028

Innovative Nanocarriers: Elastic Aspasomes Loaded with Metformin Hydrochloride for Effective Management of Melasma: In Vitro Studies and Clinical Appraisal

2026 · Rofida Albash, Abdurrahman M. Fahmy, et al. · Pharmaceutics · 12

A cross-sectional analysis of the association between diabetes self-care practices and blood glucose regulation among Egyptian diabetic patients.

2023 · E A Wahsh, A E Abou Warda, et al. · PubMed · 5

Parthanatos drives cognitive decline in repeated brain trauma: MSC-derived exosomes as a novel therapeutic strategy

2025 · Heba Mohammed Refat M. Selim, Amira A. El-Gazar, et al. · Frontiers in Pharmacology · 3

Immediate and short-term outcomes of in-hospital canagliflozin initiation in acute heart failure: Results from the CANA-AHF randomized clinical trial

2025 · Rabab A. EL-Gazar, Bassem Zarif, et al. · Heart & Lung · 3

Advancing Photodynamic Cancer Therapy with Smart Light-Responsive Lipid and Polymeric Nanocarriers: Evidence from a Meta-Analysis of Efficacy and Pharmacokinetics

2025 · Ahmed M. Agiba, Rabab A. El-Gazar, et al. · Pharmaceuticals · 1

Gut Microbiota-Derived Extracellular Vesicles in Cancer: Friends or Foes?

2026 · Heba Mohammed Refat M. Selim, Dalaal M. Abdallah, et al. · Probiotics and Antimicrobial Proteins

Hydroxychloroquine and Azithromycin Combination in the Management of COVID-19 Infection: Safety and Effectiveness Challenges

2021 · Ahmed E. Abou Warda, Mahmoud Tammam, et al. · Current Drug Safety

Works count: 7

Citation count: 24

H-index: 3

I10-index: 1